Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Express Scripts Holding Company (ESRX) Message Board

Latest Express Scripts (ESRX) Headlines Technic

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 85
Posted On: 03/12/2014 8:48:58 PM
Avatar
Posted By: Stock_Tracker
Latest Express Scripts (ESRX) Headlines

Technical Notes on Equities Reaching New 52-Weeks Highs: Host Hotels & Resorts, Express Scripts Holding, VMware, and E*TRADE Financial
PR Newswire - Wed Mar 12, 11:06AM CDT
On Tuesday, March 11, 2014, the NASDAQ Composite finished at 4,307.19, down 0.63% for the day. The Dow Jones Industrial Average closed the session at 16,351.25, down 0.41%, and the S&P 500 ended the day at 1,867.63, lower by 0.51%. The losses were broad based as nine out of ten sectors ended the session in negative. Investor-Edge.com looks at some of the equities that hit a new 52-week high during the last session. These include Host Hotels & Resorts Inc. (NYSE: HST), Express Scripts Holding Company (NASDAQ: ESRX), VMware Inc. (NYSE: VMW), and E*TRADE Financial Corporation (NASDAQ: ETFC). Free research on these four companies can be accessed at:

Collaborations, Treatment Approvals, New Solutions, Clinical Trial Results, and New Drug Applications - Analyst Notes on Biogen Idec, Johnson & Johnson, Express Scripts, Merck, and Forest Laboratories
PR Newswire - Wed Mar 12, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Biogen Idec Inc. (NASDAQ: BIIB), Johnson & Johnson (NYSE: JNJ), Express Scripts Inc. (NASDAQ: ESRX), Merck & Co. Inc. (NYSE: MRK), and Forest Laboratories Inc. (NYSE: FRX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

ADHD Medication Use Continues to Climb, Biggest Gains Seen Among Adults
PR Newswire - Wed Mar 12, 6:00AM CDT
The number of Americans who use medication to treat Attention Deficit Hyperactivity Disorder (ADHD) rose 36 percent in 5 years, totaling more than 4.8 million privately insured individuals in 2012, according to the most current and comprehensive analysis of these medications released today by Express Scripts (NASDAQ: ESRX).

Express Scripts (ESRX) Approaches New Upside Target of $79.28
Comtex SmarTrend(R) - Tue Mar 11, 10:15AM CDT
Shares of Express Scripts (NASDAQ:ESRX) have bullishly opened above the pivot of $78.33 today and have reached the first resistance level of $78.96. Analysts will be watching for a cross of the next upside pivot targets of $79.28 and $80.23.

Express Scripts Up 17.9% Since SmarTrend Uptrend Call (ESRX)
Comtex SmarTrend(R) - Mon Mar 10, 9:22AM CDT
SmarTrend identified an Uptrend for Express Scripts (NASDAQ:ESRX) on November 14th, 2013 at $66.18. In approximately 4 months, Express Scripts has returned 17.90% as of today's recent price of $78.02.

Express Scripts Earnings Hindsight: Up 1.5% in Last 18 Days (ESRX)
Comtex SmarTrend(R) - Mon Mar 10, 7:56AM CDT
When Express Scripts (NASDAQ:ESRX) reported earnings two weeks ago on February 20th, 2014, analysts, on average, expected the company to report earnings of $1.12 on sales of $25.5 billion. Express Scripts actually reported earnings of $1.12 per share on sales of $25.8 billion, beating EPS estimates by $0.00 and beating revenue estimates by $277.6 million. Shares of Express Scripts have climbed from $77.12 to $78.30, representing a gain of 1.5% since the company reported earnings 18 days ago.

Express Scripts (ESRX) Breaks Through Resistance at $77.93
Comtex SmarTrend(R) - Thu Mar 06, 9:36AM CST
Express Scripts (NASDAQ:ESRX) has opened bullishly above the pivot of $76.39 today and has reached the first level of resistance at $77.93. Should the shares continue to rise, the resistance pivots of $78.70 and $81.01 will be of interest.

Google, Ebay: Why A Top Mutual Fund Likes Them
at Investor's Business Daily - Tue Mar 04, 5:20PM CST
In this corner stands Dodge & Cox Stock Fund , the top-ranked heavyweight. It outperformed all U.S. large-cap stock funds with at least $50 billion in assets over the 12 months ended Feb. 28, according to Morningstar Inc. The $52.4 billion portfolio...

Express Scripts Rises 1.61% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Mar 04, 4:55PM CST
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $75.03 to a high of $75.78. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $75.74 on volume of 5.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Watch for Express Scripts to Potentially Pullback After Gaining 1.61% Yesterday
Comtex SmarTrend(R) - Tue Mar 04, 4:54PM CST
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $75.03 to a high of $75.78. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $75.74 on volume of 5.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

11 Million Examples of Obamacare's Higher Costs
Keith Speights, The Motley Fool - Motley Fool - Sat Mar 01, 12:30PM CST
How many Americans will pay higher insurance premiums as a result of Obamacare? That's the question posed by Congress to the Centers for Medicare and Medicaid Services, or CMS. More specifically, Congress required the Chief Actuary of CMS to give...

13.8% Return Seen to Date on SmarTrend Express Scripts Call (ESRX)
Comtex SmarTrend(R) - Fri Feb 28, 5:21PM CST
SmarTrend identified an Uptrend for Express Scripts (NASDAQ:ESRX) on November 14th, 2013 at $66.18. In approximately 4 months, Express Scripts has returned 13.80% as of today's recent price of $75.31.

SmarTrend Watching for Potential Pullback in Shares of Express Scripts After 1.01% Gain
Comtex SmarTrend(R) - Fri Feb 28, 4:16PM CST
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $74.51 to a high of $75.74. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $74.74 on volume of 7.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

3 Stocks Pushing The Health Care Sector Higher
at The Street - Fri Feb 28, 11:02AM CST
TheStreet highlights 3 stocks pushing the health care sector higher today.

Next Support Level for Express Scripts (ESRX) is $73.34
Comtex SmarTrend(R) - Thu Feb 27, 9:06AM CST
Express Scripts (NASDAQ:ESRX) has opened bearishly below the pivot of $74.05 today and has reached the first level of support at $73.67. Investors may be interested in a cross of the next downside pivot targets of $73.34 and $72.63.

Express Scripts Workers' Compensation Solution Helps Payers Address the Rising Cost of Physician Dispensing
PR Newswire - Thu Feb 27, 7:30AM CST
Medications dispensed through a physician's office are often repackaged and priced as much as 60 to 300 percent higher than an identical drug dispensed at a pharmacy to workers receiving treatment due to on-the-job injuries. Today, Express Scripts (NASDAQ: ESRX) announced the launch of a new Physician-Dispensed Medication Solution to provide workers' compensation payers visibility into their true total pharmacy costs and help reduce costs resulting from physician dispensing of medications.

Does the Latest HCV Breakthrough Therapy Spell Trouble for Gilead Sciences, Inc.?
Cory Renauer, The Motley Fool - Motley Fool - Wed Feb 26, 4:30PM CST
Gilead Sciences was the first to submit its highly anticipated hepatitis C virus (HCV) combination therapy to the FDA. Recently, Bristol-Myers Squibb earned a Breakthrough Therapy designation for its dual regimen, likely to compete with...

Stephanie Link: Express Scripts Has a Prescription For Growth
at The Street - Tue Feb 25, 3:52PM CST
Express Scripts is one of the largest PBM (Pharmacy Benefit Management) companies in the U.S. with over 1.5 billion in administered prescriptions a year. It is an industry bellwether, has a strong new management team and a solid balance sheet. 2013...

Here's What You Don't Know about UnitedHealth Group, Today's Best Dow Stock
Alex Planes, The Motley Fool - Motley Fool - Mon Feb 24, 11:24AM CST
The Dow Jones Industrial Average is having a pretty good day today, as investors seem more convinced than before that recent indications of economic weakness are more the result of bad weather than the beginning of a major downturn. The index is...


(0)
(0)




Express Scripts Holding Company (ESRX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us